1 / 30

Global Animal Vaccine Market Research Report: Forecast (2021-2026)

According to MarkNtel Advisors research report Global Animal Vaccines Market Analysis 2021 the market is likely to grow at a CAGR of around 7.4% in the forecast period of 2021-26

marknteladvisors
Télécharger la présentation

Global Animal Vaccine Market Research Report: Forecast (2021-2026)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. marknteladvisors.com Global Animal Vaccine Market Analysis, 2021

  2. Document Outline Table of Content Market Segmentation, Scope of Work 02 Research Process & Methodology Key questions answered in the report, Research process, Primary Research, Secondary Research, Respondent Profile 15 Sample Pages Global Animal Vaccine Market Analysis, 2021 22 49 Commercials Company Profile About the company 51 53 Contact Details 2 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  3. Market Segmentation Global Animal Vaccine Market By Region By Type By Disease By Technology By Company • Elanco • Ceva • PhibroAnimal Health Corporation • Neogen Corporation • Intas Pharmaceuticals Ltd. • BiogénesisBagó • OurofinoSaúde Animal • Virbac • Zoetis • Merc & Co., Inc. • Boehringer Ingelheim International GmbH • North America • USA • Canada • South America • Brazil • Others • Europe • UK • Germany • France • Spain • Italy • Others • Middle East & Africa • Saudi Arabia • UAE • South Africa • Others • Asia-Pacific • China • India • Thailand • Japan • Australia • Others • Avian influenza • Bacterial • Foot & mouth disease (FMD) • Lumpy skin • Rabies • Others (Swine influenza, Parvovirus, Distemper, Viral, Salmonella) • Live Attenuated Vaccines • Livestock Inactivated Vaccines • Toxoid Vaccines • Recombinant Vaccines • Other (DNA vaccines) Porcine Vaccines • • Aquaculture Vaccines • Ruminants Vaccines • Companion Animal Vaccines • Canine Vaccine • Feline Vaccines • Poultry Vaccines • Livestock Vaccines 3 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  4. Historical Year: (2016-19) Base Year: 2020 Table of Content (1/11) Forecast Year: (2021-26) Table of Content 1. Introduction 1.1. Product Definition 1.2. Research Process 1.3. Assumptions 1.4. Market Segmentation 2. Preface 3. Executive Summary 4. Impact of COVID-19 on Global Animal Vaccines Market 5. Global Animal Vaccines Market Trends & Insights 6. Global Animal Vaccines Market Dynamics 6.1. Growth Drivers 6.2. Challenges 6.3. Impact Analysis 7. Global Animal Vaccines Market Hotspot & Opportunities 8. Global Animal Vaccines Market Regulations and Policies 9. Global Animal Health Market Overview 10. Animal Vaccine Research & Development Process Map 11. Global Animal Vaccines Market Outlook, 2016-2026F 11.1.Market Size & Analysis 11.1.1. Market Revenue (USD Million) 4 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  5. Historical Year: (2016-19) Base Year: 2020 Table of Content (2/11) Forecast Year: (2021-26) Table of Content 11.2.Market Share & Analysis 11.2.1. By Type 11.2.1.1. Porcine Vaccines 11.2.1.2. Aquaculture Vaccines 11.2.1.3. Ruminants Vaccines 11.2.1.4. Companion Animals Vaccines 11.2.1.4.1. Canine Vaccines 11.2.1.4.2. Feline Vaccines 11.2.1.5. Poultry Vaccines 11.2.1.6. Livestock Vaccines 11.2.2. By Diseases 11.2.2.1. Avian influenza 11.2.2.2. Bacterial 11.2.2.3. Foot & mouth disease (FMD) 11.2.2.4. Lumpy skin 11.2.2.5. Rabies 11.2.2.6. Others (Swine influenza, Parvovirus, Distemper, Viral, Salmonella) 11.2.3. By Technology 11.2.3.1. Live Attenuated Vaccines 11.2.3.2. Livestock Inactivated Vaccines 5 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  6. Historical Year: (2016-19) Base Year: 2020 Table of Content (3/11) Forecast Year: (2021-26) Table of Content 11.2.3.3. Toxoid Vaccines 11.2.3.4. Recombinant Vaccines 11.2.3.5. Other (DNA vaccines) 11.2.4. By Region 11.2.4.1. North America 11.2.4.2. South America 11.2.4.3. Europe 11.2.4.4. Asia Pacific 11.2.4.5. Middle East and Africa 11.2.5. By Competitors 11.2.5.1. Competition Characteristics 11.2.5.2. Market Share & Analysis 11.2.5.3. Competitive Matrix 12. North America Animal Vaccines Market Outlook, 2016-2026F 12.1.Market Size & Analysis 12.1.1. Market Revenue (USD Million) 12.2. Market Share & Analysis 12.2.1. By Type 12.2.2. By Diseases 12.2.3. By Technology 6 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  7. Historical Year: (2016-19) Base Year: 2020 Table of Content (4/11) Forecast Year: (2021-26) Table of Content 12.2.4. By Country 12.2.4.1. The US 12.2.4.2. Canada 12.3.The US Animal Vaccines Market Outlook, 2016-2026F 12.3.1. Market Size & Analysis 12.3.1.1. Market Revenue (USD Million) 12.3.2. Market Share & Analysis 12.3.2.1. By Type 12.4.Canada Animal Vaccines Market Outlook, 2016-2026F 12.4.1. Market Size & Analysis 12.4.1.1. Market Revenue (USD Million) 12.4.2. Market Share & Analysis 12.4.2.1. By Type 13. South America Animal Vaccines Market Outlook, 2016-2026F 13.1.Market Size & Analysis 13.1.1. Market Revenue (USD Million) 13.2.Market Share & Analysis 13.2.1. By Type 13.2.2. By Diseases 13.2.3. By Technology 7 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  8. Historical Year: (2016-19) Base Year: 2020 Table of Content (5/11) Forecast Year: (2021-26) Table of Content 13.2.4. By Country 13.2.4.1. Brazil 13.2.4.2. Others 13.3.Brazil Animal Vaccines Market Outlook, 2016-2026F 13.3.1. Market Size & Analysis 13.3.1.1. Market Revenue (USD Million) 13.3.2. Market Share & Analysis 13.3.2.1. By Type 14. Europe Animal Vaccines Market Outlook, 2016-2026F 14.1.Market Size & Analysis 14.1.1. Market Revenue (USD Million) 14.2.Market Share & Analysis 14.2.1. By Type 14.2.2. By Diseases 14.2.3. By Technology 14.2.4. By Country 14.2.4.1. Germany 14.2.4.2. The UK 14.2.4.3. France 14.2.4.4. Italy 8 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  9. Historical Year: (2016-19) Base Year: 2020 Table of Content (6/11) Forecast Year: (2021-26) Table of Content 14.2.4.5. Spain 14.2.4.6. Others 14.3.Germany Animal Vaccines Market Outlook, 2016-2026F 14.3.1. Market Size & Analysis 14.3.1.1. Market Revenue (USD Million) 14.3.2. Market Share & Analysis 14.3.2.1. By Type 14.4.The UK Animal Vaccines Market Outlook, 2016-2026F 14.4.1. Market Size & Analysis 14.4.1.1. Market Revenue (USD Million) 14.4.2. Market Share & Analysis 14.4.2.1. By Type 14.5.France Animal Vaccines Market Outlook, 2016-2026F 14.5.1. Market Size & Analysis 14.5.1.1. Market Revenue (USD Million) 14.5.2. Market Share & Analysis 14.5.2.1. By Type 14.6.Italy Animal Vaccines Market Outlook, 2016-2026F 14.6.1. Market Size & Analysis 14.6.1.1. Market Revenue (USD Million) 9 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  10. Historical Year: (2016-19) Base Year: 2020 Table of Content (7/11) Forecast Year: (2021-26) Table of Content 14.6.2. Market Share & Analysis 14.6.2.1. By Type 14.7.Spain Animal Vaccines Market Outlook, 2016-2026F 14.7.1. Market Size & Analysis 14.7.1.1. Market Revenue (USD Million) 14.7.2. Market Share & Analysis 14.7.2.1. By Type 15. Asia Pacific Animal Vaccines Market Outlook, 2016-2026F 15.1.Market Size & Analysis 15.1.1. Market Revenue (USD Million) 15.2.Market Share & Analysis 15.2.1. By Type 15.2.2. By Diseases 15.2.3. By Technology 15.2.4. By Country 15.2.4.1. China 15.2.4.2. India 15.2.4.3. Japan 15.2.4.4. Thailand 15.2.4.5. Australia 10 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  11. Historical Year: (2016-19) Base Year: 2020 Table of Content (8/11) Forecast Year: (2021-26) Table of Content 15.2.4.6. Others 15.3.China Animal Vaccines Market Outlook, 2016-2026F 15.3.1. Market Size & Analysis 15.3.1.1. Market Revenue (USD Million) 15.3.2. Market Share & Analysis 15.3.2.1. By Type 15.4.India Animal Vaccines Market Outlook, 2016-2026F 15.4.1. Market Size & Analysis 15.4.1.1. Market Revenue (USD Million) 15.4.2. Market Share & Analysis 15.4.2.1. By Type 15.5.Japan Animal Vaccines Market Outlook, 2016-2026F 15.5.1. Market Size & Analysis 15.5.1.1. Market Revenue (USD Million) 15.5.2. Market Share & Analysis 15.5.2.1. By Type 15.6.Thailand Animal Vaccines Market Outlook, 2016-2026F 15.6.1. Market Size & Analysis 15.6.1.1. Market Revenue (USD Million) 15.6.2. Market Share & Analysis 11 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  12. Historical Year: (2016-19) Base Year: 2020 Table of Content (9/11) Forecast Year: (2021-26) Table of Content 15.6.2.1. By Type 15.7.Australia Animal Vaccines Market Outlook, 2016-2026F 15.7.1. Market Size & Analysis 15.7.1.1. Market Revenue (USD Million) 15.7.2. Market Share & Analysis 15.7.2.1. By Type 16. Middle East & Africa Animal Vaccines Market Outlook, 2016-2026F 16.1.Market Size & Analysis 16.1.1. Market Revenue (USD Million) 16.2.Market Share & Analysis 16.2.1. By Type 16.2.2. By Diseases 16.2.3. By Technology 16.2.4. By Country 16.2.4.1. Saudi Arabia 16.2.4.2. UAE 16.2.4.3. South Africa 16.2.4.4. Others 16.3.Saudi Arabia Animal Vaccines Market Outlook, 2016-2026F 16.3.1. Market Size & Analysis 12 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  13. Historical Year: (2016-19) Base Year: 2020 Table of Content (10/11) Forecast Year: (2021-26) Table of Content 16.3.1.1. Market Revenue (USD Million) 16.3.2. Market Share & Analysis 16.3.2.1. By Type 16.4.South Africa Animal Vaccines Market Outlook, 2016-2026F 16.4.1. Market Size & Analysis 16.4.1.1. Market Revenue (USD Million) 16.4.2. Market Share & Analysis 16.4.2.1. By Type 17. Key Strategic Imperatives for Success and Growth 18. Competition Outlook (Whichever Applicable) 18.1.Competition Matrix 18.1.1. Target Markets 18.1.2. Research & Development 18.1.3. Collaborations & Strategic Alliances 18.1.4. Key Business Expansion Initiatives 18.1.5. Business Restructuring – Mergers, Acquisitions, JVs 18.1.6. Strategic Initiatives 18.2.Company Profiles (Business Description, Product Categories, Market Focused Product Category, Business Segments, Market Focused Business Segment, Financials, Strategic Alliances/ Partnerships, Future Plans) 18.2.1. Elanco 18.2.2. Ceva 13 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  14. Historical Year: (2016-19) Base Year: 2020 Table of Content (11/11) Forecast Year: (2021-26) Table of Content 18.2.3. PhibroAnimal Health Corporation 18.2.4. Neogen Corporation 18.2.5. Intas Pharmaceuticals Ltd. 18.2.6. Biogénesis Bagó 18.2.7. Ourofino Saúde Animal 18.2.8. Virbac 18.2.9. Zoetis 18.2.10. Merc & Co., Inc. 18.2.11. Boehringer Ingelheim International GmbH 19. Disclaimer 14 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  15. Document Outline Table of Content Market Segmentation, Scope of Work 02 Research Process & Methodology Key questions answered in the report, Research process, Primary Research, Secondary Research, Respondent Profile 15 Sample Pages Global Animal Vaccine Market Analysis, 2021 22 49 Commercials Company Profile About the company 51 Contact Details 53 15 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  16. Global Animal Vaccine Market Outlook, 2016-2026F Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  17. Global Animal Vaccine Market Analysis, 2016-2026F Figure XX: Global Animal Vaccine Market Revenues (USD Million), 2016- 2026F Revenue: XX% Revenue: XX% CAGR CAGR 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F Revenue (USD million) Source: MarkNtel Advisors, E: Estimated, F: Forecast Market at a Glance • The growing prevalence of zoonotic diseases that can be transferred to human beings had negatively impacted humans lives, that had escalated the growth of animal vaccines around the globe during 2016-2019. For instance: In 2019, the CDC, in collaboration with USDA and the U.S. Department of the Interior, stated that most common illness transmitted between animals to human beings includes swine flu (H1N1), anthrax, and West Nile virus, rabies, Lyme disease, brucellosis, and others. • During 2020, the global animal vaccine market was increased due to the Covid-19 pandemic. It was mainly due to speculations which were spread that Coronavirus was transmitted through birds which negatively influenced the livestock industry. However, laboratories such as IDEXX and other companies testedvarious animals for the virus, and the results turned out to be negative. 17 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  18. Global Animal Vaccine Market, By Type (1/4) Table XX: Global Animal Vaccine Market Revenue (USD Million), By Type 2016- 2026F 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Porcine Vaccines XX XX XX XX XX XX XX XX XX XX XX Aquaculture Vaccines XX XX XX XX XX XX XX XX XX XX XX Ruminants Vaccines XX XX XX XX XX XX XX XX XX XX XX Companion Animal Vaccine XX XX XX XX XX XX XX XX XX XX XX Poultry Vaccine XX XX XX XX XX XX XX XX XX XX XX Livestock Vaccine XX XX XX XX XX XX XX XX XX XX XX Source: MarkNtel Advisors 18 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  19. Global Animal Vaccine Market, By Diseases (1/4) Table XX: Global Animal Vaccine Market Revenue (USD Million), By Diseases 2016- 2026F 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Avian Influenzas XX XX XX XX XX XX XX XX XX XX XX Bacterial XX XX XX XX XX XX XX XX XX XX XX Foot and Mouth Disease XX XX XX XX XX XX XX XX XX XX XX Lumpy Skin XX XX XX XX XX XX XX XX XX XX XX Rabies XX XX XX XX XX XX XX XX XX XX XX Others XX XX XX XX XX XX XX XX XX XX XX Source: MarkNtel Advisors 19 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  20. Global Animal Vaccine Market, By Technology (1/4) Table XX: Global Animal Vaccine Market Revenue (USD Million), By Technology 2016- 2026F 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Live Attenuated Vaccine XX XX XX XX XX XX XX XX XX XX XX Livestock Inactivated Vaccines XX XX XX XX XX XX XX XX XX XX XX Toxoid Vaccines XX XX XX XX XX XX XX XX XX XX XX Recombinant Vaccine XX XX XX XX XX XX XX XX XX XX XX Others (DNA Vaccines) XX XX XX XX XX XX XX XX XX XX XX Source: MarkNtel Advisors 20 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  21. Global Animal Vaccine Market Revenue Share, By Company Figure XX: Global Animal Vaccine Market Revenue Share (%), By Company, 2020 Others Elanco  XX  XX  XX  XX XX XX  XX  XX XX Merc & Co. Ceva XX USD XX Billion  XX  XX  XX  XX  XX  XX XX XX Zoetis Virbac  XX  XX  XX  XX  XX  XX Source: MarkNtel Advisors, 21 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  22. North America Animal Vaccine Market Outlook, 2016-2026F Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  23. North America Animal Vaccine Market Analysis, 2016-2026F Figure XX: North America Animal Vaccine Market Revenues (USD Million), 2016- 2026F Revenue: XX% Revenue: XX% CAGR CAGR 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F Revenue (USD million) Source: MarkNtel Advisors, E: Estimated, F: Forecast Market at a Glance • The North American animal vaccine market captured a significant growth rate during 2016-2019. The increasing adoption of animals escalated the demand for vaccination to prepare the immune system to fight the diseases. Additionally, high consumption of animal meat and animal productsincreases the vulnerability of the transmission of zoonotic disease to human beings. • For instance: Based on a 2019 report CDC in collaboration with USDA and the U.S. Department of the Interior released that more than 94.7 million cattle in the U.S. and more than 74.6 million pigs are at risk of zoonotic diseases transmitting to humans and remains a risk in the future as well. Moreover, in 2020, the animal vaccine market in North America increased for dogs, cats, and other animals that may were at risk of exposure to Coronavirus. As Coronavirus variant has impacteddogs and cats in North America with mild symptoms of limiting. 23 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  24. North America Animal Vaccine Market, Growth Analysis By Type (2/4) Figure XX: North America Animal Vaccine Market Opportunity Metrix, By Type, 2021-26 100% XX Growth, XX Market Share High Poultry Vaccines • The poultry vaccines market has increased in the XX past few years in North America. The rising occurrence of zoonotic diseases, growing poultry Market Share (%) population, and poultry vaccination had derived XX the demand for poultry-based food such as 50% XX chicken, eggs, and meat in North America. • Moreover, the increasing acceptance of vegetarian food coupled with the increasing adoption of XX vegan food would undesirably impact the growth XX XX of the North American poultry vaccines market in the forecast period. Low High 0% • For instance: in 2020, the study on the number of 0% 13% 25% American followed based diet has increased by 300% and nearly 9.6 million population CAGR 2021-2026F consumed vegan food. Source: MarkNtel Advisors, 24 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  25. North America Animal Vaccine Market, Growth Analysis By Diseases (2/4) Figure XX: North America Animal Vaccine Market Opportunity Metrix, By Diseases, 2021-26 100% XX Growth, XX Market Share High Bacterial • The consumption of animal-based food and XX products has increased owing to the growth of distribution channels and changes in climatic Market Share (%) conditions and changing in trade rise in the XX spreadof bacterial diseases caused by pathogens. 50% XX • The most common bacterial zoontic diseases such as anthrax, brucellosis, bovine tuberculosis, Listeriosis, Salmonellosis, Leptospirosis, Cat XX scratch disease and Psittacosis constitute a XX XX growing threat to ruminant communities. Therefore, the increasing positive influence on the Low High 0% consumption of meat and dairy products due to 0% 13% 25% their nutritional content is expected to escalate the ruminants vaccines to reduce the risk of CAGR 2021-2026F bacterial diseases transmission to humans. Source: MarkNtel Advisors, 25 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  26. North America Animal Vaccine Market, Growth Analysis By Technology (2/4) Figure XX: North America Animal Vaccine Market Opportunity Metrix, By Technology, 2021-26 100% XX Growth, XX Market Share High Live AttenuatedVaccine • Some of the live attenuated vaccines such as oral XX polio vaccine, vaccinia vaccine, Adenovirus oral vaccine, yellow fever vaccine are easily available in Market Share (%) North America. The growing incidence of canine XX disorders, in turn, adoption of vaccination for the 50% XX rising pet population in North America had positively influenced the market of live attenuated vaccines. For instance: The Human Society of the XX United States from 2015-2018 data stated that XX approximately 3.2 million shelter animals are adopted each year (1.6 million dogs and 1.6 Low High 0% million cats). Therefore, to boost the immune 0% 13% 25% system of animals and reduce the impact of the virus and pathogen-related diseases live CAGR 2021-2026F attenuatedvaccine demand would increase in the Source: MarkNtel Advisors, 26 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  27. The US Animal Vaccine Market Outlook, 2016-2026F Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  28. The US Animal Vaccine Market Analysis, 2016-2026F Figure XX: The US Animal Vaccine Market Revenues (USD Million), 2016- 2026F Revenue: XX% Revenue: XX% CAGR CAGR 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F Revenue (USD million) Source: MarkNtel Advisors, E: Estimated, F: Forecast Market at a Glance • The United States animal vaccine market share has increased at an influential rate during 2016-2019. It is mainly due to the growing awareness to maintain the health of the pet and increasing hospital expenditure of pet animals that have escalated the growth of animal vaccines in the United States. In addition, with the rising adoption of pet animals in the United States, various key players such as Zoetis, Inc., Elanco, Merck & Co, Inc. have announced partnership, merger, and acquisition to increase their share and competitiveness in the US market by developing vaccines and drug to cure animal diseases. • XX • XX 28 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  29. Document Outline Table of Content Market Segmentation, Scope of Work 02 Research Process & Methodology Key questions answered in the report, Research process, Primary Research, Secondary Research, Respondent Profile 15 Sample Pages Global Nutraceuticals Market Analysis, 2021 22 Commercials 49 Company Profile About the Company 51 53 Contact Details 29 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

  30. +1 604 800 2671, +91 8719999009 sales@marknteladvisors.com 30 Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.

More Related